FG
TNDM icon

Formula Growth’s Tandem Diabetes Care TNDM Stock Holding History

Formula Growth’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
70,304
-524
-0.7% -$9.15K 0.37% 100
2026
Q1 		$1.36M Sell
70,828
-91
-0.1% -$1.98K 0.61% 61
2025
Q4 		$1.56M Sell
70,919
-51,177
-42% -$924K 0.6% 66
2025
Q3 		$1.48M Hold
122,096
– – 0.53% 71
2025
Q2 		$2.28M Sell
122,096
-1,849
-1% -$36.6K 0.86% 48
2025
Q1 		$2.37M Sell
123,945
-2,020
-2% -$59.1K 0.96% 44
2024
Q4 		$4.54M Sell
125,965
-2,160
-2% -$73.1K 1.54% 17
2024
Q3 		$5.43M Buy
128,125
+3,479
+3% +$148K 1.87% 8
2024
Q2 		$5.02M Buy
124,646
+900
+0.7% +$37.5K 1.82% 11
2024
Q1 		$4.38M Buy
123,746
+83,000
+204% +$2.22M 1.4% 19
2023
Q4 		$1.21M Hold
40,746
– – 0.39% 99
2023
Q3 		$846K Buy
40,746
+17,000
+72% +$467K 0.29% 107
2023
Q2 		$583K Hold
23,746
– – 0.19% 121
2023
Q1 		$964K Sell
23,746
-23,507
-50% -$973K 0.31% 100
2022
Q4 		$2.12M Buy
47,253
+3,500
+8% +$158K 0.6% 66
2022
Q3 		$2.09M Hold
43,753
– – 0.6% 70
2022
Q2 		$2.59M Sell
43,753
-5,000
-10% -$410K 0.72% 55
2022
Q1 		$5.67M Sell
48,753
-3,676
-7% -$429K 1.07% 33
2021
Q4 		$7.89M Sell
52,429
-3,556
-6% -$480K 1.4% 22
2021
Q3 		$6.68M Sell
55,985
-9,000
-14% -$992K 0.96% 33
2021
Q2 		$6.33M Hold
64,985
– – 0.87% 32
2021
Q1 		$5.74M Buy
64,985
+50,485
+348% +$4.69M 0.83% 36
2020
Q4 		$1.39M Hold
14,500
– – 0.23% 107
2020
Q3 		$1.65M Hold
14,500
– – 0.31% 93
2020
Q2 		$1.43M Buy
14,500
+5,000
+53% +$399K 0.24% 96
2020
Q1 		$611K Buy
+9,500
New +$666K 0.12% 120

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Formula Growth's TNDM Position: Q2 2026 in Review

Formula Growth reduced its Tandem Diabetes Care (TNDM) stake by 0.74% in Q2 2026, selling an estimated $9.15K and leaving 70,304 shares worth $1.06M. The position accounts for 0.37% of the portfolio, ranked #100.

Formula Growth first reported a position in TNDM in Q1 2020 and has held it in 26 quarters since. The position peaked at $7.89M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Formula Growth held 70,304 shares of Tandem Diabetes Care worth $1.06M as of Q2 2026.
  • Formula Growth sold 524 Tandem Diabetes Care shares in Q2 2026, an estimated $9.15K.
  • Tandem Diabetes Care made up 0.37% of Formula Growth's portfolio in Q2 2026, its #100 holding.
  • Formula Growth first reported a position in Tandem Diabetes Care in Q1 2020 and has held it in 26 quarters since.
  • Formula Growth's Tandem Diabetes Care position peaked at $7.89M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.